Cargando...
The impact of public coverage of newer hepatitis C medications on utilization, adherence, and costs in British Columbia
BACKGROUND: Sofosbuvir and ledipasvir-sofosbuvir are both newer direct-acting antiviral agents for the treatment of hepatitis C. The high list prices for both drugs have led to concern about the budget impact for public drug coverage programs. Therefore, we studied the impact of public prescription...
Gardado en:
| Publicado en: | PLoS One |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Public Library of Science
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920374/ https://ncbi.nlm.nih.gov/pubmed/33647068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247843 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|